TCGA database analysis demonstrated that TET2 and EGFR mutations, as well as PTEN-EGFR mutations, are mutually exclusive, respectively, in non-small cell lung cancer (NSCLC) (Fig. 6d). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.